Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates
08:45am, Wednesday, 06'th May 2026
United Therapeutics (UTHR) came out with quarterly earnings of $5.82 per share, missing the Zacks Consensus Estimate of $6.73 per share. This compares to earnings of $6.63 per share a year ago.
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
06:30am, Wednesday, 06'th May 2026
The formulation is being developed in collaboration with United Therapeutics Corporation United Therapeutics made an additional $5 million payment to MannKind to support the rapid advancement of ralin
United Therapeutics Corporation Reports First Quarter 2026 Financial Results
06:30am, Wednesday, 06'th May 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter
Ahead of United Therapeutics (UTHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Tuesday, 05'th May 2026
Evaluate the expected performance of United Therapeutics (UTHR) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its ke
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Monday, 04'th May 2026
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
07:00am, Wednesday, 29'th Apr 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the term for Professor Raymond Dw
United Therapeutics Corporation $UTHR Shares Bought by Comerica Bank
06:00am, Monday, 27'th Apr 2026
Comerica Bank boosted its position in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 2.4% during the undefined quarter, according to the company in its most recent disclosure with the Sec
United Therapeutics (NASDAQ:UTHR) CFO Sells $209,609.40 in Stock
05:05am, Monday, 27'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 364 shares of the company's stock in a transaction dated Wednesday, April 22nd. The shares were sold at an aver
United Therapeutics (UTHR) to Report Q1 Results: Wall Street Expects Earnings Growth
11:03am, Wednesday, 22'nd Apr 2026
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics: The Future Lies With Manufactured Organs
08:51am, Wednesday, 22'nd Apr 2026
United Therapeutics is rated a long-term Buy, driven by its pioneering efforts in xenotransplantation and organ manufacturing. Current revenue relies heavily on treprostinil-based therapies, but futur
United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
07:00am, Wednesday, 22'nd Apr 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2026 financial results in a pre
Asset Management One Co. Ltd. Has $11.70 Million Stake in United Therapeutics Corporation $UTHR
03:25am, Tuesday, 21'st Apr 2026
Asset Management One Co. Ltd. decreased its stake in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 5.1% during the undefined quarter, according to the company in its most recent disclosu
CPRX or UTHR: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 20'th Apr 2026
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two stocks is more attractive to val
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that 11 new data presentations across
